Iris pharma

Some people are missing the colored portion of the eye, iris that can be caused by a birth defector tissue-thin iris can be damaged later by an accident or injury so, an artificial iris invented, which can improve quality of life and cosmetic appearance. The artificial iris is flexible and it can fit through a small incision and it is hand-painted to have a very natural appearance.

Iris Pharma specializes in offering preclinical and clinical ophthalmology research services worldwide. Contract research organization (CRO) dedicated to ophthalmology, Iris Pharma helps clients to navigate every stage of the drug and medical device development process like in vivo ocular efficacy studies, Good Laboratory Practice (GLP) preclinical studies, bioanalysis, clinical trials, and marketing surveys.Iris Pharmabring nearly 70 ocular drugs and medical devices to market in the past 27 years, and offers consulting services that help clients to determine the best indication for molecules and products in development.

    Related Conference of Iris pharma

    September 16-17, 2025

    20th International Conference on Ophthalmology and Vision Science

    Amsterdam, Netherlands
    September 22-23, 2025

    8th International Eye and Vision Congress

    Amsterdam, Netherlands
    October 20-21, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    November 03-04, 2025

    39th European Ophthalmology Congress

    Rome, Italy
    January 12-13, 2026

    26th Global Ophthalmologists Annual Meeting

    London, UK
    April 20-21, 2026

    3rd International Conference on Ophthalmology

    Barcelona, Spain

    Iris pharma Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in